New drug could double survival time in patients with advanced pancreatic cancer
View as a Web Page
News Medical
 
  Hepatology Hepatology logo  
  The latest hepatology news from News Medical  
 Prebiotic fiber supplement reduces harmful gut metabolites and improves liver healthPrebiotic fiber supplement reduces harmful gut metabolites and improves liver health
 
A study conducted at the University of Jyväskylä, Finland, was the first to investigate the effects of prebiotic xylo-oligosaccharides (XOS) on fatty liver in humans.
 
 
 New drug could double survival time in patients with advanced pancreatic cancerNew drug could double survival time in patients with advanced pancreatic cancer
 
A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in The New England Journal of Medicine.
 
   Collagen exists as liquid droplets inside living cells, study revealsCollagen exists as liquid droplets inside living cells, study reveals
 
Collagen, the protein that builds skin, bones, tendons and organs, exists inside cells as a liquid-like droplet rather than the long, rigid rod seen in textbooks over the last half century, according to a new study from the Centre for Genomic Regulation (CRG) in Barcelona.
 
   Evidence strengthens connection between alcohol and pancreatic cancerEvidence strengthens connection between alcohol and pancreatic cancer
 
A new paper led by researchers at University of Victoria's Canadian Institute for Substance Use Research (CISUR) contributes to mounting evidence that alcohol use can cause pancreatic cancer.
 
   Autonomous medical AI outperforms doctors in simulated EHR casesAutonomous medical AI outperforms doctors in simulated EHR cases
 
MIRA, an autonomous AI agent tested in a sandboxed electronic health record, diagnosed 574 real emergency department cases with 88.9% accuracy and outperformed physicians in a matched 311-case comparison. The system ordered tests, generated medication plans, and made admission decisions in simulation, but the authors stress that prospective validation, governance, and physician oversight are still essential.
 
 Gut microbes control liver genes by flipping DNA switches
 
Gut microbes control liver genes by flipping DNA switchesA local research study led by scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) has uncovered how the gut microbiome can influence gene activity in the liver by acting on short stretches of regulatory DNA that function like molecular "switches".
 
 
 Scientists uncover protein-folding mechanism linked to diabetes progression
 
Scientists uncover protein-folding mechanism linked to diabetes progressionOrigami masters turn simple sheets of paper into ornate sculptures. In the origami of life, our cells must fold proteins into specific three-dimensional shapes before they can carry out their biological jobs.
 
 
 PMOS rethink reframes a common hormone disorder as a whole-body disease
 
PMOS rethink reframes a common hormone disorder as a whole-body diseaseA new review reframes PCOS, now proposed as PMOS, as a systemic endocrine and metabolic disorder shaped by genetic, epigenetic, ovarian, metabolic, and neuroendocrine pathways. It highlights why inconsistent diagnosis and symptom-focused care have limited progress, while targeted therapies, biomarkers, machine learning, and organ-on-chip models may support more personalized treatment.
 
 
 Gut microbes may help explain why obesity and type 2 diabetes become harder to reverse
 
Gut microbes may help explain why obesity and type 2 diabetes become harder to reverseThis review describes how gut microbial messengers, including SCFAs, microbiota-modified bile acids, neuroactive metabolites, and extracellular vesicles, may shape obesity and type 2 diabetes through the microbiota-gut-brain axis.
 
 
 Novel analysis identifies unique proliferation gene alterations in diverse cancer patients
 
Novel analysis identifies unique proliferation gene alterations in diverse cancer patientsNew research to be presented today (Monday) at the annual conference of the European Society of Human Genetics shows that a cancer patient's genetic ancestry can have a significant effect both on how their disease progresses and their survival.
 
 
 Study identifies genetic marker associated with severe IBD
 
Study identifies genetic marker associated with severe IBDIn the largest genetic study of inflammatory bowel disease (IBD) traits to date, researchers have identified a genetic marker that is associated with more severe ulcerative colitis and Crohn's disease – the major forms of IBD.
 
 
 Long daily naps increase liver disease risk in diabetic patients
 
Long daily naps increase liver disease risk in diabetic patientsPeople with type 2 diabetes who nap longer than 30 minutes every day, regardless of their sleep patterns at night, increase their risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.
 
 
 Microplastics worsen liver damage under high-fat dietary conditions
 
Microplastics worsen liver damage under high-fat dietary conditionsMicroplastics – minuscule pieces of plastic broken down from larger plastic waste – are a growing concern for human health, especially for the liver.
 
 
 Novel IL1RAP therapy advances toward pancreatic cancer clinical trial
 
Novel IL1RAP therapy advances toward pancreatic cancer clinical trialBlocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to new research.
 
 
 New EHR-based marker flags transplant patients at high risk for organ rejection
 
New EHR-based marker flags transplant patients at high risk for organ rejectionA new multicenter study led by researchers at the Icahn School of Medicine at Mount Sinai suggests that a novel electronic health record-based marker can help clinicians identify transplant patients at high risk for organ rejection due to not taking their medications as prescribed-and intervene before the rejection happens.
 
 
 Synthetic protein hybrid offers promising treatment for liver diseases
 
Synthetic protein hybrid offers promising treatment for liver diseasesThe research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold).
 
 
 GATA6 loss transforms colorectal cancer cells into metastatic states
 
GATA6 loss transforms colorectal cancer cells into metastatic statesLoss of GATA6-a transcription factor that controls which genes are turned on or off-can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors, according to Weill Cornell Medicine and Massachusetts Institute of Technology researchers.
 
 
 Diabetes raises mortality risk after solid-organ transplantation
 
Diabetes raises mortality risk after solid-organ transplantationPeople with an organ transplant who develop or have existing diabetes are more likely to die than those without diabetes, according to a comprehensive analysis of solid-organ transplant recipients, which is being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.
 
 
 Chronic pancreatitis care must expand beyond simple pain management
 
Chronic pancreatitis care must expand beyond simple pain managementChronic pancreatitis (CP) diminishes quality-of-life (QoL) across mobility, self-care, daily activities, mental health, and pain-not just abdominal discomfort-according to a new Mayo Clinic study available online on August 27, 2025, and published in Volume 9, Issue 1 of the Journal of Pancreatology on March 30, 2026.
 
 
 Novel metal-free prodrug suppresses cancer spread in preclinical models
 
Novel metal-free prodrug suppresses cancer spread in preclinical modelsA carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine.
 
 
 Review outlines how donor imaging improves liver transplantation outcomes
 
Review outlines how donor imaging improves liver transplantation outcomesLiver transplantation often depends on decisions made under pressure. In deceased donation, teams must quickly judge whether a liver is suitable, whether fat accumulation could threaten graft function, and whether unexpected vascular anatomy may complicate procurement or implantation.
 
 
 Immunotherapy helps bridge cancer patients to curative liver transplantation
 
Immunotherapy helps bridge cancer patients to curative liver transplantationLiver transplantation remains one of the most powerful curative options for hepatocellular carcinoma (HCC) because it removes both the tumor and the diseased liver.
 
 
 Gene therapy shows promise against deadly childhood liver disease
 
Gene therapy shows promise against deadly childhood liver diseaseA new gene therapy has been used to successfully treat a deadly childhood liver disease using mice that model this disease by researchers at UCL and Great Ormond Street Hospital.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026